Decreased maternal plasma apelin concentrations in preeclampsia

Hypertension in Pregnancy

Volumn 31, Issue 4, 2012, Pages 398-404

  Bortoff, Katherine D ^a   Qiu, Chunfang ^b   Runyon, Scott ^a   Williams, Michelle A ^b   Maitra, Rangan ^a  

^a RTI INTERNATIONAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apelin; APJ; Epidemiology; Hypertension; Preeclampsia

Indexed keywords

APELIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MATERNAL AGE; MATERNAL PLASMA; PREECLAMPSIA; RISK ASSESSMENT; SMOKING;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PRE-ECLAMPSIA; PREGNANCY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84867083345     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2012.690054     Document Type: Article

References (19)

1. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol 2010; 5:173-192.
2. Carpene C, Dray C, Attane C, et al. Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 2007; 63:359-373.
3. Medhurst AD, Jennings CA, Robbins MJ, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003; 84:1162-1172.
4. Hus-Citharel A, Bouby N, Frugiere A, Bodineau L, Gasc JM, Llorens-Cortes C. Effect of apelin on glomerular hemodynamic function in the rat kidney. Kidney Int 2008; 74:486-494.
5. Charo DN, Ho M, Fajardo G, et al. Endogenous regulation of cardiovascular function by apelin- APJ. Am J Physiol Heart Circ Physiol 2009; 297:H1904-H1913.
6. Kasai A, Shintani N, Kato H, et al. Retardation of retinal vascular development in apelindeficient mice. Arterioscler Thromb Vasc Biol 2008; 28:1717-1722.
7. Kidoya H, Naito H, Takakura N. Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 2010; 115:3166-3174.
8. Kourtis A, Giomisi A, Mouzaki M, et al. Apelin levels in normal pregnancy. Clin Endocrinol (Oxford) 2011; 75(3):367-371.
9. Cobellis L, De Falco M, Mastrogiacomo A, et al. Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histol Histopathol 2007; 22:1-8.
10. Liao YM, Qiao FY. Expression of apelin in placentas of patients with hypertensive disorders complicating pregnancy. Zhonghua Fu Chan Ke Za Zhi 2007; 42:382-385.
11. Zhang C, Williams MA, King IB, et al. Vitamin C and the risk of preeclampsia: Results from dietary questionnaire and plasma assay. Epidemiology 2002; 13:409-416.
12. American College of Obstetricians and Gynecologists. Guidelines for Women's Health Care: A Resource Manual. 3rd ed., Washington, DC: American College of Obstetricians and Gynecologists, 2007.
13. Malamitsi-Puchner A, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D, Briana DD. Circulating apelin concentrations in mother/infant pairs at term. Acta Paediatr 2007; 96:1751-1754.
14. Mesmin C, Dubois M, Becher F, Fenaille F, Ezan E. Liquid chromatography/tandem mass spectrometry assay for the absolute quantification of the expected circulating apelin peptides in human plasma. Rapid Commun Mass Spectrom 2010; 24:2875-2884.
15. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed., Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008.
16. Goetze JP, Rehfeld JF, Carlsen J, et al. Apelin: A new plasma marker of cardiopulmonary disease. Regul Pept 2006; 133:134-138.
17. Kalea AZ, Batlle D. Apelin and ACE2 in cardiovascular disease. Curr Opin Investig Drugs 2010; 11:273-282.
18. Anton L, Brosnihan KB. Systemic and uteroplacental renin-angiotensin system in normal and pre-eclamptic pregnancies. Ther Adv Cardiovasc Dis 2008; 2:349-362.
19. Xia Y, Ramin SM, Kellems RE. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 2007; 50:269-275.